A single-center, randomized, parallel controlled study comparing the efficacy and safety aspects of three anthracycline-based regimens as neoadjuvant chemotherapy in primary breast cancer

This study aimed to compare the efficacy and safety aspects of three anthracycline-based regimens as neoadjuvant chemotherapy in primary breast cancer. Five-hundred and one patients with clinical stage I–III invasive breast cancer were randomly assigned to receive four cycles of neoadjuvant chemothe...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Breast Cancer Res Treat
Päätekijät: Zhou, Yijun, Ouyang, Tao, Xie, Yuntao, Wang, Tianfeng, Fan, Zhaoqing, He, Yingjian, Lu, Aiping, Liu, Yiqiang, Li, Jinfeng
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Springer US 2016
Aiheet:
Clinical Trial
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4903108/
https://ncbi.nlm.nih.gov/pubmed/27250001
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-016-3843-7
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia